NR1H4 and metabolic dysfunction-associated steatotic liver disease: Emerging data showed that inhibiting ileal FXR-FGF15 induced beneficial effects alleviating non-alcoholic fatty liver disease (NAFLD), obesity, and insulin resistance (53, 54).